Network meta-analysis: A map to navigate the maze of treatment for advanced hepatocellular carcinoma

Affiliations

¹ Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London W120HS, UK; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
² Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072, Italy; Drug Development Unit, Sarah Cannon Research Institute UK, London, UK.
³ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072, Italy; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan 20089, Italy. Electronic address: lorenza.rimassa@hunimed.eu.

Comment

Antonio D'Alessio et al. Eur J Intern Med. 2023 May.

. 2023 May:111:32-34.

doi: 10.1016/j.ejim.2023.02.015. Epub 2023 Feb 23.

¹ Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London W120HS, UK; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
² Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072, Italy; Drug Development Unit, Sarah Cannon Research Institute UK, London, UK.
³ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072, Italy; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan 20089, Italy. Electronic address: lorenza.rimassa@hunimed.eu.

No abstract available

Comment on

Dual immune checkpoint inhibitors or combined with anti-VEGF agents in advanced, unresectable hepatocellular carcinoma.
Zhang B, Tao B, Li Y, Yi C, Lin Z, Ma Y, Han J, Shao W, Chen Z, Lin J, Chen J. Zhang B, et al. Eur J Intern Med. 2023 May;111:37-46. doi: 10.1016/j.ejim.2022.12.025. Epub 2022 Dec 31. Eur J Intern Med. 2023. PMID: 36588054